| Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy SK Tripathi, M Panda, BK Biswal Food and Chemical Toxicology 125, 566-582, 2019 | 95 | 2019 |
| Cell signaling and cancer: a mechanistic insight into drug resistance M Panda, BK Biswal Molecular biology reports 46 (5), 5645-5659, 2019 | 78 | 2019 |
| SOX9: An emerging driving factor from cancer progression to drug resistance M Panda, SK Tripathi, BK Biswal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (2), 188517, 2021 | 53 | 2021 |
| Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway K Pandey, SK Tripathi, M Panda, BK Biswal Toxicology in Vitro 65, 104788, 2020 | 20 | 2020 |
| The potential of retinoids for combination therapy of lung cancer: updates and future directions SK Tripathi, K Pandey, M Panda, MJ Spinella, KR Rengasamy, BK Biswal Pharmacological research 147, 104331, 2019 | 18 | 2019 |
| Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers M Panda, SK Tripathi, G Zengin, BK Biswal Cell Biology and Toxicology 39 (1), 1-31, 2023 | 12 | 2023 |
| Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation M Panda, SK Tripathi, BK Biswal Molecular Biology Reports 47 (6), 4155-4168, 2020 | 12 | 2020 |
| Evodiamine inhibits stemness and metastasis by altering the SOX9–β‐catenin axis in non‐small‐cell lung cancer M Panda, BK Biswal Journal of Cellular Biochemistry 123 (9), 1454-1466, 2022 | 7 | 2022 |
| Synthesis of first coumarin fluorescent dye for actin visualization SK Padhan, J Bag, M Panda, BK Biswal, H Sahoo, M Mishra, SN Sahu Bioconjugate Chemistry 33 (11), 2113-2120, 2022 | 6 | 2022 |
| Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer S Biswal, M Panda, RK Sahoo, SK Tripathi, BK Biswal Archives of Oral Biology, 105697, 2023 | 4 | 2023 |
| Thiabendazole: a new class of antenna core structure for multifunctional trivalent organo-europium (Eu III) complexes S Mund, K Singh, M Panda, BK Biswal, U Subuddhi, S Vaidyanathan Journal of Materials Chemistry C 10 (29), 10645-10659, 2022 | 4 | 2022 |
| A Comprehensive Review on Pharmacology and Toxicology of Bioactive Compounds of Lagerstroemia Speciosa (L.) Pers. SK Tripathi, S Behera, M Panda, G Zengin, BK Biswal Current Traditional Medicine 7 (4), 504-513, 2021 | 3 | 2021 |
| Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy SK Tripathi, K Pandey, M Panda, BK Biswal AGO-Driven Non-Coding RNAs, 293-318, 2019 | 3 | 2019 |
| Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics RK Sahoo, SK Tripathi, S Biswal, M Panda, SS Mathapati, BK Biswal Biotechnology Journal 19 (2), 2300370, 2024 | 1 | 2024 |
| Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β‐catenin axis M Panda, S Biswal, BK Biswal Molecular Biology Reports 51 (1), 523, 2024 | | 2024 |
| Shikonin suppresses cell proliferation by inducing apoptosis in oral cancer S Biswal, M Panda, BK Biswal | | 2022 |
| SOX9 promotes gefitinib resistance in non-small cell lung carcinoma through differential expression of epithelial to mesenchymal transition markers BK Biswal, SK Tripathi, M Panda, K Pandey | | 2019 |
| Evodiamine Resensitizes Cisplatin Resistance by Targeting SOX9and# 946; catenin Axis in Non Small Cell Lung Cancer M Panda Rourkela, 0 | | |
